source
- Bipartisan House bill would require security review of U.S. biotech investments in ChinaA bipartisan group of Representatives introduced legislation on Tuesday that would expand the Committee on Investment and National Security (COINS) Act to cover biotechnology. The bill, called the…
- Eli Lilly partners with Ascidian Therapeutics on $1.9 b RNA exon-editing collaboration for kidney diseaseEli Lilly and Boston-based Ascidian Therapeutics announced a research collaboration aimed at discovering medicines for genetically driven kidney diseases. The partnership leverages Ascidian’s RNA e…